Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Total 13F shares
-
3,349,153
-
Share change
-
-18,326,355
-
Total reported value
-
$294,129,961
-
Put/Call ratio
-
97%
-
Price per share
-
$87.56
-
Number of holders
-
102
-
Value change
-
-$1,892,206,413
-
Number of buys
-
31
-
Number of sells
-
90
Institutional Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2016
As of 31 Mar 2016 FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) had 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,349,153 shares of stock of the company.
Largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, LPL Financial LLC, UBS Group AG, BANK OF AMERICA CORP /DE/, RAYMOND JAMES & ASSOCIATES, ROYAL BANK OF CANADA, JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), and J&P(CHINA)CAPITAL MANAGEMENT CO.,LTD.
This table shows 102 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.